Israel - hebreiska - Ministry of Health

comex ltd., israel - dexamethasone sodium phosphate - תמיסה להזרקה - dexamethasone sodium phosphate 2 mg/ml

Israel - hebreiska - Ministry of Health

meditrend marketing (2004) ltd, israel - benzoxonium chloride; chlorhexidine gluconate - תמיסה - benzoxonium chloride 1 mg/ml; chlorhexidine gluconate 5 mg/ml - chlorhexidine, combinations - chlorhexidine, combinations - to disinfect wounds and injuries, such as cuts, scratches, mild burns and insect stings.

Israel - hebreiska - Ministry of Health

bayer israel ltd - chlorhexidine dihydrochloride; dexpanthenol - קרם - dexpanthenol 5 %; chlorhexidine dihydrochloride 0.5 % - chlorhexidine, combinations - chlorhexidine, combinations - antiseptic healing treatment of wounds of any kind with an infection risk : such as slight skin irritations, wounds, cuts, burns and skin inflammation.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - טבליה - erythromycin as stearate 500 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophylaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - טבליה - erythromycin as stearate 250 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophlaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

Israel - hebreiska - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - טבליה - erythromycin as stearate 250 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophlaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

Israel - hebreiska - Ministry of Health

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 400 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

Israel - hebreiska - Ministry of Health

j-c health care ltd - darunavir as ethanolate - טבליות מצופות פילם - darunavir as ethanolate 600 mg - darunavir - darunavir - prezista , co-administered with 100 mg ritonavir (prezista/rtv), and with other antiretroviral agents, is indicated for the treatment of human immunodeficiency virus (hiv-1) infection for over 18 years of age.

Israel - hebreiska - Ministry of Health

abic marketing ltd, israel - lamivudine as anhydrous; zidovudine - טבליה - zidovudine 300 mg; lamivudine as anhydrous 150 mg - zidovudine - zidovudine - antiretroviral combination therapy for the treatment of hiv infected adults and adolescents over the age of 12 years.

Israel - hebreiska - Ministry of Health

glaxo smith kline (israel) ltd - lamivudine - טבליות מצופות פילם - lamivudine 150 mg - lamivudine - lamivudine - epivir (lamivudine) is indicated for use in combination with retrovir (zidovudine) for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.